Transcend Capital Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,118
| Closed | -$212K | – | 508 |
|
|
2022
Q2 | $212K | Buy |
+4,118
| New | +$212K | 0.02% | 443 |
|
|
2022
Q1 | – | Sell |
-2,223
| Closed | -$318K | – | 536 |
|
|
2021
Q4 | $318K | Buy |
2,223
+588
| +36% | +$84.1K | 0.03% | 379 |
|
|
2021
Q3 | $221K | Sell |
1,635
-305
| -16% | -$41.2K | 0.02% | 435 |
|
|
2021
Q2 | $412K | Sell |
1,940
-95
| -5% | -$20.2K | 0.06% | 222 |
|
|
2021
Q1 | $369K | Sell |
2,035
-660
| -24% | -$120K | 0.04% | 283 |
|
|
2020
Q4 | $301K | Buy |
+2,695
| New | +$301K | 0.04% | 293 |
|